1. Home
  2. ADUS vs TXG Comparison

ADUS vs TXG Comparison

Compare ADUS & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Addus HomeCare Corporation

ADUS

Addus HomeCare Corporation

HOLD

Current Price

$110.12

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$20.58

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADUS
TXG
Founded
1979
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
ADUS
TXG
Price
$110.12
$20.58
Analyst Decision
Buy
Hold
Analyst Count
10
14
Target Price
$138.40
$15.61
AVG Volume (30 Days)
150.4K
2.2M
Earning Date
02-23-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
4.66
N/A
Revenue
$1,346,596,000.00
$641,814,000.00
Revenue This Year
$25.50
$4.50
Revenue Next Year
$7.11
N/A
P/E Ratio
$23.54
N/A
Revenue Growth
18.77
1.92
52 Week Low
$88.96
$6.78
52 Week High
$136.72
$20.72

Technical Indicators

Market Signals
Indicator
ADUS
TXG
Relative Strength Index (RSI) 44.72 70.44
Support Level $105.21 $19.04
Resistance Level $113.94 $20.30
Average True Range (ATR) 2.71 0.86
MACD 0.21 0.41
Stochastic Oscillator 55.67 96.63

Price Performance

Historical Comparison
ADUS
TXG

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, mainly to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are medical in nature to those individuals who may require assistance during an illness or after surgery.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: